EVALUATION OF IN VITRO ANTI-MALARIAL ACTIVITY USING BETA HEMATIN FORMATION INHIBITION METHOD

 1.0  INTRODUCTION:

Malaria is one of the most important infectious diseases in the world that is caused by intracellular parasitic protozoa of the genus Plasmodium and it is transmitted via the bite of an infected female Anopheles sp mosquito. During infection, Plasmodium passes over several stages including an intra-erythrocytic stage, in which the parasite degrades 60–80% of host hemoglobin that is used as food support for its development and growth. Hemoglobin is oxidized to methemoglobin within parasite digestive vacuole and is hydrolyzed by aspartic proteases into free heme (Fe3+) (ferriprotoporphyrin IX) and denatured globin. Globin is hydrolyzed by cysteine proteases (i.e. falciparum) and exopeptidases into small peptides and amino acids used for protein synthesis. Digestion of hemoglobin releases large quantities of heme (Fe3+) that accumulate and reaches high concentrations (up to 300–500 mM). Those high concentrations are thought to be toxic for Plasmodium through membrane disruption, lipid peroxidation, and protein and DNA oxidation. Free heme (Fe3+) might also interfere with the hemoglobin degradation pathway. Plasmodium uses a system to detoxify heme (Fe3+) called biocrystallization based on the formation of hemozoin pigment which appears as a dark black crystalline spot (a dark brown pigment) in red blood cells of infected patients.


  


 

2.0 METHODOLOGY:

·       Different concentrations (0–2 mg/mL in DMSO) of the extracts will be incubated with 3mM of hematin, 10 mM oleic acid, and 1M HCl.

·       The final volume will be adjusted to 1mL using sodium acetate buffer, pH 5.

·       Similarly the positive control chloroquine diphosphate will be prepared.

·       Finally, the reaction mixtures will be incubated overnight at 37˚C with constant gentle shaking.

·       After incubation, samples will be centrifuged at 14,000rpm, 10 min, at 21˚C and the hemozoin pellet will be repeatedly washed with incubation (15 min at 37˚C with regular shaking) in 2.5% (w/v) sodium dodecyl sulfate (SDS) in phosphate-buffered saline followed by a final wash in 0.1 M sodium bicarbonate until the supernatant will clear (usually 3–8 washes).

·     After the final wash, the supernatant will be removed and the pellets will be dissolved in 1 mL of 0.1 M NaOH.

·       Absorbance will be measured at 400nm using a spectrophotometer. The results will be recorded as %inhibition of heme.

·   Crystallization compared to the negative control (DMSO) using the following equation:

 

(%) percentage inhibition = [(AN−AS)/AN] × 100

 

Where AN: absorbance of negative control and AS is the absorbance of test samples.

 

3.0 ENDPOINT PARAMETER(S):

·       % Percentage inhibition activity

 

4.0 REFERENCE(S):

4.1 Solmaz Asnaashari, Fariba Heshmati AfsharSedigheh Bamdad Moghadam, and Abbas Delazar. Evaluation of In Vitro Antimalarial Activity of Different Extracts of Eremostachys azerbaijanica Rech.f. Iran J Pharm Res. 2016 Summer; 15(3): 523–529.

4.2 Mahdi Mojarrab, Ali Shiravand, Abbas Delazar, and Fariba Heshmati Afshar. Evaluation of In Vitro Antimalarial Activity of Different Extracts of Artemisia aucheri Boiss. and A. armeniaca Lam. and Fractions of the Most Potent Extracts. The Scientific World Journal Volume 2014, Article ID 825370, 6 pages http://dx.doi.org/10.1155/2014/825370.

4.3 Herraiz, T., Guillén, H., González-Peña, D. et al. Antimalarial Quinoline Drugs Inhibit β-Hematin and Increase Free Hemin Catalyzing Peroxidative Reactions and Inhibition of Cysteine Proteases. Sci Rep 9, 15398 (2019). https://doi.org/10.1038/s41598-019-51604-z.


END OF DOCUMENTS

You may like to read these links: 

1. List of All SOPs and Documents for Microbiology Laboratory

2. List of All SOPs and Documents for In-vivo Laboratory

3. List of All SOPs and Documents for In-vitro Laboratory

4. List of All SOPs and Documents for Animal House Facility

5. List of All SOPs and Documents for Clinical Research

6. List of 32 Respiratory Pre-Clinical Study Models and Related Details

7. List of Pharmacological Study Models with details about disease Inducing agents, Standard or Reference drugs, and related parameters

SHARE

Owner

Hi. I’m Writer of Researchsop.com. ’ ’ Please share these SOPs to all concern pharma people for their development. I like to fullfill the need of curious people. These things inspire me to make things looks better.

  • Image
  • Image
  • Image
  • Image
  • Image
    Blogger Comment
    Facebook Comment

0 comments:

Post a Comment